首页> 美国卫生研究院文献>Scientific Reports >Impact of blood urea nitrogen to creatinine ratio on mortality and morbidity in hemodialysis patients: The Q-Cohort Study
【2h】

Impact of blood urea nitrogen to creatinine ratio on mortality and morbidity in hemodialysis patients: The Q-Cohort Study

机译:血液尿素氮与肌酐比对血液透析患者死亡率和发病率的影响:Q队列研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The association between blood urea nitrogen to creatinine ratio (UCR) and survival is uncertain in hemodialysis patients. We examined the influence of UCR on mortality and morbidity in hemodialysis patients. A total of 3,401 hemodialysis patients were prospectively followed for 4 years. The association between UCR with overall survival was analyzed using a Cox regression model. During a 4-year follow-up period, 545 patients died from any cause and 582 experienced MACE, 392 with coronary heart disease (CHD), 114 with infection-related death, 77 with hemorrhagic stroke, 141 with ischemic stroke, and 107 with cancer death. Every 1 increase in UCR level was significantly associated with an increased risk for all-cause mortality (hazard ratio [HR] 1.07; 95% confidence interval [CI] 1.03–1.12), CHD (HR 1.08; 95% CI 1.02–1.14), and infection-related death (HR 1.11; 95% CI 1.02–1.21). There was no evidence of a significant association between UCR and death from cancer, and incidence of stroke. A high UCR was significantly associated with an increased risk for all-cause mortality, infection-related death and incidence of CHD in hemodialysis patients.
机译:在血液透析患者中​​,血尿素氮与肌酐比(UCR)与生存之间的关联尚不确定。我们检查了UCR对血液透析患者死亡率和发病率的影响。总共对3,401名血液透析患者进行了为期4年的随访。使用Cox回归模型分析了UCR与总生存期之间的关联。在4年的随访期内,有545名患者因任何原因死亡,582例经历过MACE,392例患有冠心病(CHD),114例与感染相关的死亡,77例出血性中风,141例缺血性中风,107例癌症死亡。 UCR水平每升高1倍,导致全因死亡率的风险增加(危险比[HR] 1.07; 95%置信区间[CI] 1.03–1.12),冠心病(HR 1.08; 95%CI 1.02–1.14) ,以及与感染相关的死亡(HR 1.11; 95%CI 1.02-1.21)。没有证据表明UCR与癌症死亡和中风发生率之间存在显着关联。高UCR与血液透析患者全因死亡率,感染相关死亡和冠心病发生率增加的风险显着相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号